Evolving challenges with long-term care of liver transplant recipients
- PMID: 37545440
- DOI: 10.1111/ctr.15085
Evolving challenges with long-term care of liver transplant recipients
Abstract
The number of liver transplants (LT) performed worldwide continues to rise, and LT recipients are living longer post-transplant. This has led to an increasing number of LT recipients requiring lifelong care. Optimal care post-LT requires careful attention to both the allograft and systemic issues that are more common after organ transplantation. Common causes of allograft dysfunction include rejection, biliary complications, and primary disease recurrence. While immunosuppression prevents rejection and reduces incidences of some primary disease recurrence, it has detrimental systemic effects. Most commonly, these include increased incidences of metabolic syndrome, various malignancies, and infections. Therefore, it is of utmost importance to optimize immunosuppression regimens to prevent allograft dysfunction while also decreasing the risk of systemic complications. Institutional protocols to screen for systemic disease and heightened clinical suspicion also play an important role in providing optimal long-term post-LT care. In this review, we discuss these common complications of LT as well as unique considerations when caring for LT recipients in the years after transplant.
Keywords: allograft rejection; biliary complications; immunosuppression; liver transplant; post-transplant infection; post-transplant malignancy; post-transplant metabolic syndrome.
© 2023 The Authors. Clinical Transplantation published by John Wiley & Sons Ltd.
Similar articles
-
Management of the Liver Transplant Recipient: Approach to Allograft Dysfunction.Med Clin North Am. 2016 May;100(3):477-86. doi: 10.1016/j.mcna.2016.01.001. Epub 2016 Mar 17. Med Clin North Am. 2016. PMID: 27095640 Review.
-
De novo malignancies after liver transplantation: The effect of immunosuppression-personal data and review of literature.World J Gastroenterol. 2019 Sep 21;25(35):5356-5375. doi: 10.3748/wjg.v25.i35.5356. World J Gastroenterol. 2019. PMID: 31558879 Free PMC article.
-
Improving long-term outcomes after liver transplantation.Clin Liver Dis. 2014 Aug;18(3):717-30. doi: 10.1016/j.cld.2014.05.011. Clin Liver Dis. 2014. PMID: 25017085 Review.
-
Posttransplant biopsy risk for stable long-term pediatric liver transplant recipients: 451 percutaneous biopsies from two multicenter immunosuppression withdrawal trials.Am J Transplant. 2019 May;19(5):1545-1551. doi: 10.1111/ajt.15255. Epub 2019 Feb 4. Am J Transplant. 2019. PMID: 30614623 Free PMC article. Clinical Trial.
-
Immunosuppression after pediatric liver transplant: The parents' perspective.Clin Transplant. 2023 Apr;37(4):e14931. doi: 10.1111/ctr.14931. Epub 2023 Feb 27. Clin Transplant. 2023. PMID: 36774540
Cited by
-
Metabolic Disorders in Liver Transplant Recipients: The State of the Art.J Clin Med. 2024 Feb 9;13(4):1014. doi: 10.3390/jcm13041014. J Clin Med. 2024. PMID: 38398327 Free PMC article. Review.
-
Complications in Post-Liver Transplant Patients.J Clin Med. 2023 Sep 24;12(19):6173. doi: 10.3390/jcm12196173. J Clin Med. 2023. PMID: 37834818 Free PMC article. Review.
-
Immunosuppressive Induction Therapy Using the Antithymocyteglobulin Grafalon: A Single-Center Non-Interventional Study.J Clin Med. 2024 Jul 11;13(14):4051. doi: 10.3390/jcm13144051. J Clin Med. 2024. PMID: 39064090 Free PMC article.
References
REFERENCES
-
- Moon AM, Singal AG, Tapper EB. contemporary epidemiology of chronic liver disease and cirrhosis. Clin Gastroenterol H. 2019;18:2650-2666.
-
- Younossi ZM, Stepanova M, Younossi Y, et al. Epidemiology of chronic liver diseases in the USA in the past three decades. Gut. 2020;69:564.
-
- Termeie O, Fiedler L, Martinez L, et al. Alarming trends: mortality from alcoholic cirrhosis in the United States. Am J Med. 2022;135(10):1263-1266. 10.1016/j.amjmed.2022.05.015
-
- Sepanlou SG, Safiri S, Bisignano C, et al. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 2020;5:245-266.
-
- Starzl TE, Iwatsuki S, Van Thiel DH, et al. Evolution of liver transplantation. Hepatology. 1982;2:614S-636S.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical